RxDoctor Payments Data

David Hykes, DO

Gastroenterology · Sandusky, OHNPI 1992763155

Payments from drug & device makers

$4,316in general payments, 2019–2025

Across 287 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$597
  • Takeda Pharmaceuticals U.S.A., Inc.$593
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$537
  • Pfizer$270
  • Intercept Pharmaceuticals, Inc.$133
  • plus $940 from 18 others

What the payments were for

  • Food & beverage$4,29299%
  • Education$241%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,316 in reported general payments places this provider in the 60th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio

Medicare billing

Part B allowed, 2024
$65,886
Medicare patients
317
Services billed
543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZenpepLipase/Protease/Amylase18$43,178
CreonLipase/Protease/Amylase30$37,647
LinzessLinaclotide24$18,814
Budesonide DrBudesonide26$7,464
Sucralfate208$7,452
Pantoprazole Sodium349$3,209
Budesonide EcBudesonide21$2,850
Colestipol Hcl60$2,828
Dicyclomine Hcl136$2,239
Lubiprostone16$1,620
Omeprazole156$1,573
Esomeprazole Magnesium16$762
WaterWater For Irrigation,sterile12$525
Amitriptyline Hcl44$478
Famotidine36$451

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,247$56,46154 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 657 gastroenterology providers in Ohio.

Other gastroenterology in Sandusky

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →